Pre-operative Rehabilitation Exercise Program for Total Knee Arthroplasty (PREP)
The purpose of this study is to determine whether a pre-operative home rehabilitation exercise program designed for knee replacements is more effective than pre-operative usual care.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
|Official Title:||Impact of a Pre-operative Rehabilitation Exercise Program for Patients With Severe Dysfunction Awaiting Total Knee Arthroplasty|
- Self-reported function [ Time Frame: 5 evaluations within 6 months after surgery ] [ Designated as safety issue: No ]
- Quality of life, self-efficacy, ambulation, anxiety and patient satisfaction [ Time Frame: 5 evaluations within 6 months after surgery ] [ Designated as safety issue: No ]
|Study Start Date:||July 2008|
|Estimated Study Completion Date:||June 2015|
|Primary Completion Date:||July 2013 (Final data collection date for primary outcome measure)|
physical therapy home exercise
Patients with lower levels of function prior to total knee arthroplasty (TKA) attain lower functional endpoints after surgery. Therapeutic exercise improves function in patients with arthritis of the knee, yet little evidence has examined the impact of pre-operative exercise for TKA.
Single blinded randomized clinical trial comparing a pre-operative home exercise program to pre-operative usual care for patients who are waiting for TKA.Comparison group is usual care within the health region which does not include pre-operative rehabilitation program.
Primary outcome: WOMAC function subscale. Secondary outcomes: 1) quality of life; 2) ambulation; 3) self-efficacy; 4) anxiety; 5) patient satisfaction; 6) cost-effectiveness of this intervention.
Total Enrollment: 230 patients
If the intervention improves function prior to surgery, results will be clinically applicable for patients waiting for surgery
Please refer to this study by its ClinicalTrials.gov identifier: NCT00493142
|University of Alberta- Capital Health|
|Edmonton, Alberta, Canada, T6G 2G4|
|Principal Investigator:||Allyson Jones, PhD||University of Alberta|
|Study Director:||Lauren Beaupre, PhD||Capital Health- UAH|